{
  "abstract": "Background and Importance Since 2005, the Spanish Ministry of Health has promoted the Patient Safety Strategy within the National Health System (SNS) to improve patient safety culture. Strategic Line 2 focuses on safe clinical practices, including medication reconciliation to ensure safe medication use. In 2025, García Orcoyen Hospital implemented medication reconciliation for patients admitted to emergency department in observation beds.Aim and Objectives Determine the incidence and types of medication discrepancies in observation bed patients. Analyse discrepancy types and physicians’ responses. Assess prescribing quality and the reconciliation process.Material and Methods A retrospective observational study was conducted in a regional hospital on patients admitted to emergency observation beds from January to July 2025, in whom medication reconciliation was performed. Data collected included: the number of reconciled medications, types of discrepancies (justified/unjustified), and physician responses (reconciliation error, justified, no response).To assess prescribing quality, the following indicators were evaluated: medications with reconciliation errors (RE) (%) (number of RE/number of reconciled medications). RE per patient (number of RE/number of patients with ≥1 RE)To evaluate the quality of the medication reconciliation process, the following was assessed: detected RE (number of RE/number of discrepancies requiring clarification)Results A total of 183 patients were reconciled, 45% of whom were men. The mean age was 70.6 years (IC95% 68,1-73); 1,000 discrepancies (55%) were detected, with 81.5% justified. Of the unjustified discrepancies, 20% were later justified by physicians. No discrepancies remained without medical response.Of unjutified discrepancies (185), 148 of 185 discrepancies (80%) were RE. The most affected drug groups were (number, percentage): central nervous system drugs (37, 25%), varius (36, 24,3%), cardiovascular therapy (30, 20.3%), ocular therapy (15,10.1%), hormonal therapy (7,4.7%), NSAIDs/antirheumatics therapy (6,4.1%), antidiabetics (5,3.4%), respiratory therapy (5,3.4%), antithrombotics therapy (4,2.7%), cytostatics/immunosuppressants/corticosteroids (2,1.4%), and antibiotics (1,0.7%).Prescribing quality: 8.14% (148/1819) of medications had RE, averaging 0.81 errors per patient.Quality of the medication reconciliation process: There were 0.80 medication errors (148/185) per patient.Conclusion and Relevance A high number of RE were detected. Detecting and correcting these errors is crucial to prevent patient harm, improve pharmacotherapeutic continuity, and optimise treatment. Pharmacist intervention is key to promoting patient safety.References and/or Acknowledgements 1. https://www.sefh.es/bibliotecavirtual/conciliacion/Libro_consenso_terminologia_conciliacion.pdfConflict of Interest No conflict of interest",
  "authors": [
    {
      "affiliations": [
        "Garcia Orcoyen Hospital, Pharmacy Service, Estella, Spain"
      ],
      "name": "L Cabia"
    },
    {
      "affiliations": [
        "Garcia Orcoyen Hospital, Pharmacy Service, Estella, Spain"
      ],
      "name": "P Garcia"
    },
    {
      "affiliations": [
        "Garcia Orcoyen Hospital, Pharmacy Service, Estella, Spain"
      ],
      "name": "AI Idoate"
    }
  ],
  "title": "5PSQ-025 Medication reconciliation in the emergency department performed by pharmacists",
  "uid": "69e8d382-a250-5848-b990-8a285b1bba62"
}